Recital 4, Commission Implementing Regulation (EU) No 198/2013 of 7 March 2013 on the selection of…

In forcesince 7 Mar 2013

On 3 October 2012 the Pharmacovigilance Risk Assessment Committee adopted a recommendation stating that the black symbol should be an inverted equilateral black triangle. The recommendation took into account the views of patients and healthcare professionals as expressed by the Patients’ and Consumers’ Working Party and the Healthcare Professionals’ Working Group established by the European Medicines Agency.